Medicure (CVE:MPH) Stock Passes Above Fifty Day Moving Average – Time to Sell?

Medicure Inc. (CVE:MPH) crossed above its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of C$1.14 and traded as high as C$1.20. Medicure shares last traded at C$1.20, with a volume of 2,000 shares trading hands.

Medicure Stock Performance

The firm has a market capitalization of C$12.52 million, a PE ratio of -1.76 and a beta of 0.62. The company has a debt-to-equity ratio of 6.90, a current ratio of 1.02 and a quick ratio of 1.29. The firm has a fifty day moving average price of C$1.14 and a 200 day moving average price of C$1.17.

Medicure Company Profile

Medicure Inc, a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction. It also offers ZYPITAMAG to treat patients with primary hyperlipidemia or mixed dyslipidemia. In addition, the company is developing Sodium Nitroprusside injection, and Generic ANDA 2 and 3 for acute cardiology; and TARDOCAL, to treat neurological indications.